Gabapentinoids confer survival benefit in human glioblastoma
- DOI
- 10.1038/s41467-025-59614-4
- Published
- 2025-05-15
- Container
- Nature Communications
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-025-59614-4,
title = {Gabapentinoids confer survival benefit in human glioblastoma},
author = {Joshua D. Bernstock and Mulki Mehari and Jakob V. E. Gerstl and David M. Meredith and Pablo A. Valdes and Philip Heesen and Vardhaan S. Ambati and Saritha Krishna and Jason A. Chen and Harshit Arora and Benjamin R. Johnston and Mikias Negussie and Kristina Grieco and Cesar Nava Gonzales and Abraham Dada and Anna B. Lebouille-Veldman and Aymen Kabir and Lennard Spanehl and Jasleen Kaur and Sena Oten and Youssef E. Sibih and Rania A. Mekary and Andy Daniel and John Frederick de Groot and Saef Izzy and Florian A. Gessler and Scellig Stone and Omar Arnaout and Yi Lu and Bryan D. Choi and Matthew D. Hall and Minesh P. Mehta and Yazmin Odia and Gregory K. Friedman and E. A. Chiocca and Pier Paolo Peruzzi and Timothy R. Smith and Shawn L. Hervey-Jumper},
year = {2025},
journal = {Nature Communications},
doi = {10.1038/s41467-025-59614-4},
url = {https://doi.org/10.1038/s41467-025-59614-4}
}RIS
TY - JOUR TI - Gabapentinoids confer survival benefit in human glioblastoma AU - Joshua D. Bernstock AU - Mulki Mehari AU - Jakob V. E. Gerstl AU - David M. Meredith AU - Pablo A. Valdes AU - Philip Heesen AU - Vardhaan S. Ambati AU - Saritha Krishna AU - Jason A. Chen AU - Harshit Arora AU - Benjamin R. Johnston AU - Mikias Negussie AU - Kristina Grieco AU - Cesar Nava Gonzales AU - Abraham Dada AU - Anna B. Lebouille-Veldman AU - Aymen Kabir AU - Lennard Spanehl AU - Jasleen Kaur AU - Sena Oten AU - Youssef E. Sibih AU - Rania A. Mekary AU - Andy Daniel AU - John Frederick de Groot AU - Saef Izzy AU - Florian A. Gessler AU - Scellig Stone AU - Omar Arnaout AU - Yi Lu AU - Bryan D. Choi AU - Matthew D. Hall AU - Minesh P. Mehta AU - Yazmin Odia AU - Gregory K. Friedman AU - E. A. Chiocca AU - Pier Paolo Peruzzi AU - Timothy R. Smith AU - Shawn L. Hervey-Jumper PY - 2025 JO - Nature Communications DO - 10.1038/s41467-025-59614-4 UR - https://doi.org/10.1038/s41467-025-59614-4 ER -
APA
Bernstock, J. D., Mehari, M., Gerstl, J. V. E., Meredith, D. M., Valdes, P. A., Heesen, P., Ambati, V. S., Krishna, S., Chen, J. A., Arora, H., Johnston, B. R., Negussie, M., Grieco, K., Gonzales, C. N., Dada, A., Lebouille-Veldman, A. B., Kabir, A., Spanehl, L., Kaur, J., Oten, S., Sibih, Y. E., Mekary, R. A., Daniel, A., Groot, J. F. D., Izzy, S., Gessler, F. A., Stone, S., Arnaout, O., Lu, Y., Choi, B. D., Hall, M. D., Mehta, M. P., Odia, Y., Friedman, G. K., Chiocca, E. A., Peruzzi, P. P., Smith, T. R., & Hervey-Jumper, S. L. (2025). Gabapentinoids confer survival benefit in human glioblastoma. Nature Communications. https://doi.org/10.1038/s41467-025-59614-4
Source records
- crossref · retrieved 2026-09-26T01:46:46.033Z